BociMed: Leading CMC Development with iLabPower Validation Cloud

About BociMed

BociMed is a global leader in drug delivery technology, specializing in comprehensive solutions across oral, injection, pulmonary, transdermal, ocular, mucosal, and RNA delivery methods. With over a decade of experience, BociMed’s international R&D team of 400+ scientists has completed 200+ drug development projects, supported by 600+ SOPs and extensive regulatory expertise. The company offers a full spectrum of services, including small molecule synthesis, CMC, formulation, clinical trials, and registration support, leveraging advanced technologies like LIMS and eCTD for efficient, global regulatory compliance.

Digital Transformation with iLabPower Validation Cloud

To boost operational efficiency and transition to a paperless lab environment, BociMed partnered with Neotrident to deploy the iLabPower Validation Cloud SaaS platform. This comprehensive digital solution streamlined laboratory workflows, from experimental design to data analysis, ensuring seamless, compliant, and efficient operations.

Key Benefits of the iLabPower Validation Cloud

  • Rapid Deployment: Completed system implementation and validation in just 40 work hours through effective multi-department collaboration.
  • Regulatory Compliance: Meets GXP standards with IQ and OQ validations based on GAMP5, ensuring compliance with industry regulations.
  • Risk Reduction: As a standardized cloud-based platform, Validation Cloud minimizes uncertainties and complexities compared to custom systems, ensuring compliance from the design phase.

Enhanced R&D Efficiency and Business Continuity

Within two months, BociMed achieved full digital management of its lab processes, significantly improving R&D efficiency. The integrated platform supports data acquisition, analysis, and reporting, maintaining business continuity and driving faster, more reliable outcomes.

Accelerating Global Pharmaceutical Innovation

With the iLabPower Validation Cloud, BociMed enhances its cutting-edge R&D capabilities, providing high-value services to global partners that accelerate drug development timelines and bring innovative therapies to market, ultimately advancing patient care worldwide.

Comments are closed.